| Views | |
|---|---|
| A distinctive bullous skin reaction associated with enfortumab vedotin‐ejfv treatment for metastatic urothelial cancer: A case report | 153 |
| October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| A distinctive bullous skin reaction associated with enfortumab vedotin‐ejfv treatment for metastatic urothelial cancer: A case report | 27 | 8 | 3 | 14 | 3 | 12 | 4 |
| Views | |
|---|---|
| 2021_Krause_etal.pdf | 283 |
